Skip to main content

Table 1 Lysozyme HSCORE values classified according to various characteristics of patients and tumors

From: Expression and prognostic significance of lysozyme in male breast cancer

   HSCORE *  
Characteristics n Mean ± s.e Median (range) P
Total tumors 60 85.6 ± 13.6 0 (0–320)  
Age     n.s.
   <60 15 85.3 ± 28.8 0 (0–270)  
   ≥ 60 45 85.7 ± 15.6 0 (0–320)  
Tumor size     n.s.
   T1 20 77.5 ± 22.7 0 (0–270)  
   T2 19 110 ± 27.3 100 (0–320)  
   T3–T4 21 71.4 ± 21.3 0 (0–270)  
Nodal status     n.s.
   N0 32 89.6 ± 19.7 0 (0–320)  
   N+ 28 84.1 ± 19.5 0 (0–270)  
Histological grade     n.s.
   I 12 62.5 ± 34 0 (0–320)  
   II 28 102.8 ± 20.1 110 (0–270)  
   III 20 75.5 ± 21.9 0 (0–270)  
Metastasis status     n.s.
   M0 57 87.7 ± 14.2 0 (0–320)  
   M1 3 46.6 ± 46.6 0 (0–140)  
Estrogen receptor status (fmol/mg protein)
   ≥ 10 30 81.6 ± 18.5 0 (0–270)  
   <10 3 0 0 (0)  
Histological type     n.s.
   Ductal 53 93.5 ± 14.8 0 (0–320)  
   Lobular 2 0 0 (0)  
   Papillary 3 60 ± 60 0 (0–180)  
   Cribiform 2 0 0 (0)  
  1. *Semiquantitive immunostaining score for lysozyme. s.e. = standard error; n.s. = not significant.